Jun. 16 at 11:28 PM
$PYPD We just got
$26.7 million in cash-in the grand scheme, this is a relatively mild dilution, especially considering:
The exercise price (
$3.50) is close to market, not a deep discount.
The company gains
$26.7 million in cash, which could be pivotal for getting D-PLEX approved and launched.
Future dilution from the
$4.50 warrants may not even occur unless the stock rises meaningfully.
If PolyPid executes well and D-PLEX gets approved, this could be a smart trade-off: a bit of dilution now in exchange for meaningful upside later.
Current PPS:
$3.60
Post-dilution PPS (purely financial dilution): ≈
$3.56
Dilutive impact: ~1.1% decrease in PPS
-ChatGPT
